[EN] INHIBITORS OF PEPTIDYLARGININE DEIMINASES<br/>[FR] INHIBITEURS DE PEPTIDYLARGININE DÉIMINASES
申请人:GILEAD SCIENCES INC
公开号:WO2022140390A1
公开(公告)日:2022-06-30
The present disclosure relates to novel compounds for use in therapeutic treatement of a disease associated with peptidylarginine deiminases (PADs), such as peptidylarginine deiminase type 4 (PAD4). The present disclosure also relates to processes and intermediates for the preparation of such compounds, methods of using such compounds and pharmaceutical compositions comprising the compounds described herein.
本公开涉及用于治疗与肽基精氨酸脱亚胺酶(PADs)相关的疾病(例如肽基精氨酸脱亚胺酶4型(PAD4))的新化合物。本公开还涉及用于制备这些化合物的过程和中间体,使用这些化合物的方法以及包含所述化合物的制药组合物。